NCT02933905View on ClinicalTrials.gov

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2016

Conditions
Diabetic Macular EdemaVitreomacular InterfaceAnti-VEGF Treatment
Interventions
DRUG

Intravitreal Ranibizumab injection

All Listed Sponsors
lead

Fundació Institut Germans Trias i Pujol

OTHER

NCT02933905 - Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection | Biotech Hunter | Biotech Hunter